Catalog Number 06C30-25 |
Device Problem
Low Test Results (2458)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Type
malfunction
|
Manufacturer Narrative
|
An evaluation is in process.A follow up report will be submitted when the evaluation is complete.This report is being filed on an international product, architect havab igm, list 6c30, that has a similar product distributed in the u.S., architect havab-m list 6l21.
|
|
Event Description
|
The customer observed a (b)(6) havab igm result on the architect i2000sr analyzer.The following data was provided: (b)(6); vidas 0.93 ((b)(6)), architect 0.11 and 0.11.(b)(6); vidas 1.07 ((b)(6)), architect 0.35 and 0.32.(b)(6); vidas 1.03 ((b)(6)), repeated on liaison as (b)(6), architect 0.88 and 0.89.(b)(6); vidas 0.58 ((b)(6)), repeated on liaison as (b)(6), architect 0.64 and 0.70.Per the package insert the interpretation of results is as follows: less than 0.80.Nonreactive (nr), 0.80 to 1.20 grayzone reactive (gz), greater than 1.20 reactive (r).There was no impact to patient management reported.
|
|
Manufacturer Narrative
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of instrument logs, a review of labeling and sensitivity testing.No adverse trend was identified for the customer's issue.Labeling was reviewed and found to be adequate.No patient sample was available for return, therefore, a retained kit of the complaint lot number, was tested in a sensitivity set-up and all control values met control specifications and were in the typical range.In addition, the clinical sensitivity was evaluated by testing one commercially available seroconversion panel.Sensitivity testing met all specifications.Based on all available information and abbott diagnostics' complaint investigation, no product deficiency was identified.
|
|
Search Alerts/Recalls
|
|